CRYO CELL INTERNATIONAL INC
CCELNYSE
$3.46
↓ -0.6%Jul 17 close · end-of-day
Price
1Y↓ -29.5%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$27.9M
Enterprise Value
$33.0M
P/E
—
P/S
0.9
P/B
—
EV/EBITDA
37.8
PEG
—
FCF Yield
21.9%
Dividend Yield
—
Revenue (TTM)
$31.1M
Net Income (TTM)
-$2.5M
Free Cash Flow (TTM)
$6.1M
Gross Margin
—
Operating Margin
-0.3%
Net Margin
-7.9%
ROE
13.9%
ROIC
—
Debt / Equity
-0.5
Net Cash
-$5.1M
Return 1Y
-28.7%
Company profile
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells. The company also manufactures and sells PrepaCyte CB processing system. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide.
- CEO
- David I. Portnoy
- Sector
- Services
- Industry
- Healthcare
- Employees
- 90
- Headquarters
- Florida
- Website
- cryo-cell.com
Management & directors
- Taymans Jill MVP Finance, CFO
- Portnoy DavidChairman, Co-CEO
Roles derived from SEC Form 4 filings.
Earnings
CCEL Q2 2026 Earnings
Period ends 2026-05-31
MetricActualYoY
Revenue$7.8M↓ -1.9%
Diluted EPS$0.07↑ +75.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $31.1M | $28.9M | $30.3M | $31.3M | $32.0M | $31.6M |
| Gross profit | — | — | — | — | — | — |
| Operating income | $7.7M | $4.0M | $4.0M | -$12.3M | $3.5M | $482,394.00 |
| Net income | $3.6M | $2.1M | $2.8M | -$9.5M | $402,095.00 | -$2.4M |
| Diluted EPS | $0.45 | $0.25 | $0.33 | -$1.14 | $0.05 | -$0.30 |
| Operating cash flow | $8.5M | $7.9M | $8.6M | $8.9M | $6.0M | $5.5M |
| Free cash flow | $8.4M | $6.1M | -$3.6M | $2.1M | $3.6M | $5.2M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 24.6% | 13.9% | 13.3% | -39.3% | 10.9% | 1.5% |
| Net margin | 11.6% | 7.2% | 9.1% | -30.4% | 1.3% | -7.7% |
| Line item | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.1M | $8.0M | $8.0M | $7.9M | $7.8M | $7.8M | $7.7M | $7.8M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $1.4M | -$122,347.00 | $1.1M | $1.5M | $1.9M | -$4.0M | $765,134.00 | $1.2M |
| Net income | $1.1M | -$1.9M | $282,855.00 | $355,785.00 | $749,408.00 | -$3.8M | $47,108.00 | $554,586.00 |
| Diluted EPS | $0.13 | -$0.23 | $0.03 | $0.04 | $0.09 | -$0.46 | $0.01 | $0.07 |
| Operating cash flow | $2.4M | $2.2M | $954,063.00 | $707,014.00 | $2.5M | $1.3M | $651,827.00 | $1.8M |
| Free cash flow | $2.3M | $2.1M | $892,010.00 | $644,606.00 | $2.5M | $1.2M | $584,762.00 | $1.8M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 17.2% | -1.5% | 13.3% | 18.8% | 24.3% | -50.6% | 10.0% | 15.4% |
| Net margin | 13.0% | -23.2% | 3.5% | 4.5% | 9.6% | -48.7% | 0.6% | 7.1% |
Company news
May 8, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-28 | TAYMANS JILL M· VP Finance, CFO | Option exercise | 7,500 | $3.10 | $23,250.00 | filing |
| 2025-11-21 | PORTNOY DAVID· Chairman, Co-CEO | Award | 800 | $4.04 | $3,232.00 | filing |
| 2025-11-21 | PORTNOY DAVID· Chairman, Co-CEO | Award | 677 | $4.09 | $2,768.93 | filing |
| 2025-11-21 | PORTNOY DAVID· Chairman, Co-CEO | Award | 406 | $4.09 | $1,660.54 | filing |
| 2025-11-21 | PORTNOY DAVID· Chairman, Co-CEO | Award | 273 | $4.10 | $1,119.30 | filing |
| 2025-11-20 | PORTNOY DAVID· Chairman, Co-CEO | Award | 289 | $4.00 | $1,156.00 | filing |
| 2025-11-19 | PORTNOY DAVID· Chairman, Co-CEO | Award | 1,921 | $4.08 | $7,837.68 | filing |
| 2025-11-18 | PORTNOY DAVID· Chairman, Co-CEO | Award | 640 | $4.09 | $2,617.60 | filing |
| 2025-11-17 | PORTNOY DAVID· Chairman, Co-CEO | Award | 1,429 | $4.00 | $5,716.00 | filing |
| 2025-11-12 | PORTNOY DAVID· Chairman, Co-CEO | Award | 2,040 | $4.12 | $8,404.80 | filing |
| 2025-11-11 | PORTNOY DAVID· Chairman, Co-CEO | Award | 2,474 | $4.13 | $10,217.62 | filing |
| 2025-11-10 | PORTNOY DAVID· Chairman, Co-CEO | Award | 1,026 | $4.18 | $4,288.68 | filing |
| 2025-11-04 | PORTNOY DAVID· Chairman, Co-CEO | Award | 5,000 | $4.40 | $22,000.00 | filing |
| 2025-10-31 | PORTNOY DAVID· Chairman, Co-CEO | Award | 4,666 | $4.45 | $20,763.70 | filing |
| 2025-09-18 | PORTNOY DAVID· Chairman, Co-CEO | Buy | 3,411 | $4.46 | $15,213.06 | filing |
| 2025-09-18 | PORTNOY DAVID· Chairman, Co-CEO | Buy | 1,751 | $4.49 | $7,861.99 | filing |
| 2025-09-17 | PORTNOY DAVID· Chairman, Co-CEO | Buy | 5,564 | $4.43 | $24,648.52 | filing |
| 2025-09-16 | PORTNOY DAVID· Chairman, Co-CEO | Buy | 6,449 | $4.46 | $28,762.54 | filing |
| 2025-09-10 | PORTNOY DAVID· Chairman, Co-CEO | Buy | 11,035 | $4.40 | $48,554.00 | filing |
| 2025-09-10 | PORTNOY DAVID· Chairman, Co-CEO | Buy | 7,200 | $4.48 | $32,256.00 | filing |
| 2025-09-10 | PORTNOY DAVID· Chairman, Co-CEO | Buy | 7,178 | $4.42 | $31,726.76 | filing |
| 2025-09-10 | PORTNOY DAVID· Chairman, Co-CEO | Buy | 4,817 | $4.47 | $21,531.99 | filing |
| 2025-09-10 | PORTNOY DAVID· Chairman, Co-CEO | Buy | 2,087 | $4.48 | $9,349.76 | filing |
| 2025-09-09 | PORTNOY DAVID· Chairman, Co-CEO | Buy | 4,815 | $4.49 | $21,619.35 | filing |
| 2025-09-09 | PORTNOY DAVID· Chairman, Co-CEO | Buy | 185 | $4.49 | $830.65 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.